Welcome to Arquer – developing novel urine diagnostic tests for prostate and bladder cancer

Arquer Diagnostics (Arquer) is a private, UK based diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test for bladder and prostate cancer.

Arquer Packaging

Arquer’s diagnostic test, the Mcm5-ELISA, detects the presence of minichromosome maintenance (MCM) protein, a marker for the presence of dividing cancer cells, in urine. MCM proteins are excellent biomarkers, being directly involved in cell replication, and are shed into urine by both prostate and bladder tumours. Arquer’s test is based on intellectual property licensed exclusively from Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK.
Picture of LFD in somebodies hand